TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Friday reported third-quarter earnings of $1.95 billion.

On a per-share basis, the Tarrytown, New York-based company said it had net income of $18.45. Earnings, adjusted for one-time gains and costs, were $20.07 per share.

The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $16.08 per share.

The biopharmaceutical company posted revenue of $5.12 billion in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $4.55 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REGN at https://www.zacks.com/ap/REGN